| ADC | Antibody–drug conjugate |
| ATR | Attenuated total reflection |
| CA-4 | Combretastatin A-4 |
| DBU | 1,8-Diazabicyclo[5.4.0]undec-7-ene |
| DCM | Dichloromethane |
| DMEM | Dulbecco’s modified Eagle’s medium |
| DMSO | Dimethylsulfoxide |
| ECACC | European Collection of Animal Cell Cultures |
| ER | Estrogen receptor |
| GI50 | 50% growth inhibitory concentration |
| HER2 | Human epidermal growth factor receptor 2 |
| IC50 | Half-maximal inhibitory concentration |
| LC50 | Median lethal concentration |
| MBC | Metastatic breast cancer |
| MRP | Multidrug resistance protein |
| MTA | Microtubule-targeting agent |
| NCI | National Cancer Institute |
| PBS | Phosphate-buffered saline |
| PBST | Phosphate-buffered saline with Tween 20 |
| P-gp | P-glycoprotein |
| PI | Propidium iodide |
| PIK3 | Phosphatidylinositol-4,5-bisphosphate 3-kinase |
| PR | Progesterone receptor |
| SRB | Sulphorhodamine B |
| TBAF | tert-Butylammonium fluoride |
| TBDMSCl | tert-Butyldimethylsilyl chloride |
| TGI | Total growth inhibitory concentration |
| THF | Tetrahydrofuran |
| TLC | Thin layer chromatography |
| TNBC | Triple-negative breast cancer |